| Innovation Title | Categories | Lead Inventor | |
|---|---|---|---|
|
Inhibition of a Protein-Protein Interaction as a Potential Cancer Treatment
2022-HU-69918 |
Hu (DECEASED), Changdeng | ||
|
Method for Detection of Transiently Interacting Proteins
66261 |
Tao, Weiguo Andy | ||
|
Dr. Chang-Deng Hu is a Professor of Medicinal Chemistry and Molecular Pharmacology. He received an M.D. from Bengbu Medical College, China, an M.S. in Cancer Immunology from Tongji Medical University, China, and a Ph.D. in Molecular Biology from Kobe University, Japan. Dr. Hu's research focuses on developing novel anti-cancer agents for cancer treatment, including using molecular, cellular, biochemical, genetic, and imaging approaches to study how cancer cell behaviors are regulated at the transcription and epigenetic levels. For more information, visit Dr. Hu's Purdue website: https://www.mcmp.purdue.edu/faculty/hu1 or his Hu Lab website: http://people.pharmacy.purdue.edu/~hu1/ |
|
